Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations. Academic Article uri icon

Overview

publication date

  • November 15, 2018

Identity

PubMed Central ID

  • PMC6254785

Scopus Document Identifier

  • 85115319504

Digital Object Identifier (DOI)

  • 10.1172/jci.insight.125568

PubMed ID

  • 30429379

Additional Document Info

volume

  • 3

issue

  • 22